Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1995-4-12
pubmed:abstractText
To investigate possible relationships between genetic alterations and hormonal deregulation during breast cancer development and/or progression, we examined 616 primary breast cancers for loss of heterozygosity (LOH) at chromosomal regions 16q24, 17p13.3 and 17q21, and for amplifications of the ERBB2 and c-MYC loci. A comparison of oestrogen receptor (ER) and progesterone receptor (PgR) status in tumour cells with data concerning these genetic alterations revealed that LOH at 17q21 was significantly correlated with absence of oestrogen receptors (ER) (P < 0.0003) or progesterone receptors (PgR) (P < 0.0001), and with the absence of both (P < 0.0001). Similarly, a significant association was observed between amplification of ERBB2 and the absence of either ER or PgR. LOH at 17p13.3 was associated with the absence of PgR (P < 0.01). These data suggest a possible relationship between specific genetic changes on chromosome 17 and hormonal deregulation in the progression of breast cancer.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1350457, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1354643, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1671531, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1672082, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1682035, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-1977515, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2137009, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2685334, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2825969, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2878870, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2892166, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2892175, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-2902581, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-3003577, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-3029872, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-3798106, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-6329026, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-8104866, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-8104920, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-8219249, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-8381331, http://linkedlifedata.com/resource/pubmed/commentcorrection/7880720-8437862
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0007-0920
pubmed:author
pubmed:issnType
Print
pubmed:volume
71
pubmed:geneSymbol
ERBB2
pubmed:owner
NLM
pubmed:authorsComplete
N
pubmed:pagination
438-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
pubmed:affiliation
Department of Biochemistry, Cancer Institute, Tokyo, Japan.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't